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Background: Approximately 170 million people are infected with Hepatitis C virus (HCV) worldwide. The
prevalence of chronic HCV infections in Pakistan is about 5%, with most individuals being infected with HCV
genotype 3a. Data on HCV genotypes distribution across various districts of the country are scarce. One example is
district Mardan from where such data is available only from 17 individuals. Accordingly, the present study aimed at
determining HCV genotypes distribution among 177 HCV RNA positive individuals from district Mardan.
Findings: Serum samples (n = 215) from patients suspected of hepatitis C were collected and processed for Nested
PCR based detection and subsequent genotyping. Gender-wise and age-wise differences in HCV prevalence and
HCV genotypes distribution were determined by χ2 test. Out of the total 215 serum samples, 177 were found to be
positive for HCV RNA. The genotype 3a was the most predominant genotype among HCV RNA positive samples
with a prevalence of 90.3%, followed by genotype 1a (5.6%), mixed genotypes (2.8%), genotype 3b (0.6%) and
genotype 4 (0.6%). The HCV prevalence was higher in young individuals than old people and was indicative of
reduced survival rate beyond 40 years.
Conclusion: HCV genotype 3a is the most predominant genotype in district Mardan. The state of the art preventive
and therapeutic strategies should be implemented to control the spread of HCV infections. Further temporal
studies involving different geographical areas of Pakistan, are required to improve the control measures for HCV
infection.
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Hepatitis C is an infectious disease caused by Hepatitis
C virus (HCV). HCV has a major impact on public
health with over 170 million infected individuals. It has
been considered to cause 25% of hepatocellular carcin-
oma (HCC) and 27% of cirrhosis cases all over the world
[1]. Death rate due to HCV infection is very high and
approximately 350, 000 people die every year after being
infected with HCV. It is thought that HCV is 10 times
more infectious than human immunodeficiency virus
(HIV) [2]. Toxicity, resistance and cost of the treatment
limit current therapy of HCV. To date, no vaccine or
immunotherapy is available.
HCV is an enveloped positive-strand RNA virus. It be-
longs to the genus hepacivirus that is part of Flaviviridae
family. HCV virion size is about 55–65 nm in diameter
[3]. HCV genome (approximately 9.6 kb) encodes a* Correspondence: tahiryaqub@uvas.edu.pk
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reproduction in any medium, provided the orpolyprotein of about 3,010 amino acids, which is flanked
at the 5'- and 3'- ends by small highly structured
untranslated regions (UTR). This polyprotein precursor
is cleaved by viral and cellular proteases, giving rise to
10 mature structural and nonstructural proteins. Core,
E1 and E2 are structural proteins while a small hydro-
phobic peptide p7 separates the structural proteins from
nonstructural proteins (NS). The nonstructural proteins
include NS2, NS3, NS4A, NS4B, NS5A, and NS5B [4].
HCV envelope glycoprotein E1 and E2 are important for
viral entry. HCV core protein interacts with lipid drop-
lets [5] while p7 has been shown to participate in assem-
bly and release of HCV particles [6]. NS2 has been
shown to interact with envelope glycoproteins, p7 and
NS3 and recruits viral proteins to lipid droplets [7]. NS3
protein plays a role in the recruitment of NS5A to lipid
droplets and in the assembly of viral particles [8]. The
formation of membranous web is the important function
of NS4B [9]. The interaction of NS5A and apolipopro-
tein (ApoE) is required for the assembly and export oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 3 Prevalence of different HCV genotypes in Mardan.
Table 1 Prevalence of HCV genotypes in different age
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http://www.virologyj.com/content/10/1/90infectious virions [10]. NS5B is a RNA-dependent RNA
polymerase (Dry) that is a critical enzyme for HCV RNA
replication.
HCV shows high genetic variability and therefore, it is
divided into six major genotypes and multiple subtypes.
HCV has heterogeneous geographical distribution. HCV
genotypes 4, 5 and 6 are restricted to more precise
geographic regions (i.e., South Africa and Southeast
Asia, Egypt, and Africa, correspondingly), whereas geno-
types 1, 2, and 3 have a global distribution. In addition,
being limited to different geographical areas these six
genotypes have their own distinctive pattern of disease
development and response to therapy.
In Pakistan, prevalence of HCV is 4.7% [11]. One of
the major reasons for chronic HCV infection is lack of
awareness of the disease and regular blood analysis, so
most of the individuals remain ignorant about their
status of HCV infection. A little has been reported about
HCV and its genotypes prevalence in Pakistan. Therefore,
this work has been conducted to determine baseline data
on the prevalence of HCV genotypes in a district in North
of Pakistan, the Mardan. The baseline information will
serve in better understanding of infection, awareness in
the public and subsequent control strategies.
The study was approved by Ethical Committee
Bacteriologist to Government of Punjab, Health Depart-
ment (No. 677/Bact.). From hundreds of blood samples
referred from district Mardan to The Medical Labora-
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Figure 2 Prevalence of HCV RNA positive samples in different
age groups.RNA, a total of 215 blood samples were randomly
selected to detect and genotype HCV RNA. The age of
clinically suspected hepatitis C patients was between
10–50 years. Of these 111 were males and 104 were
females. Serum from each blood sample was separated
at 3000 g for 5 min, labeled and stored at −20°C until
used within a week. RNA was extracted using Qiagen kit
(Invitrogen, Corp., California; USA) as per manufac-
turer’s instructions. Complimentary DNA (cDNA) was
synthesized using Invitrogen kit as per manufacturer’s
instructions. Briefly, 10 μL of extracted RNA was
incubated at 37°C for 60 min along with gene-specific
reverse primer and 200U of Moloney Murine Leukemia
Virus (M-MuLV) reverse transcriptase. The cDNA was
amplified through Nested PCR.
Different HCV genotypes were detected by using allele-
specific primers reported by Ohno et al. [12]. Temperature
profile of PCR machine was adjusted at 94°C for 5 min for
initial denaturation, followed by 35 cycles, each of 45 s
denaturation at 94°C, 45 s annealing at 62°C and 45 s
extension at 72°C, with final extension at 72°C for 5 min.
The final PCR product obtained either after qualitative or
genotype-specific PCR was subjected to electrophoresis in
2% agarose gel containing ethidium bromide along with
100-bp DNA ladder (Invitrogen, Corp., California; USA).
The banding pattern, to determine genotype specific
bands, was photographed in Gel Doc System. The preva-
lence and distribution of each genotype among different
age groups and sex was analyzed by Chi-square statisticsgroups
Age group Genotypes
3a 1a 3b Type 4 Mixed
genotype
Total %age
10–20 3 1 0 0 0 4 2.2%
21–30 35 0 0 0 0 35 19.7
31–40 64 3 0 0 2 69 38.9
41–50 38 5 1 0 3 47 26.5
51 - > 20 1 0 1 0 22 12.4
Total 160 10 1 1 5 177 100
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http://www.virologyj.com/content/10/1/90implemented in SPSS version 16 for windows (IBM Cor-
poration, 2008). P value < 0.05 was considered significant.
Of the total 215 sera, only 177 were positive for HCV
RNA, with almost equal representation from males and fe-
males (males = 89 (50%) and females = 88 (49%); P > 0.05;
Figure 1). Serum samples were categorized into different
age groups such as 10–20 years, 21–30 years, 31–40 years,
41–50 years and above 50 years, and percentage of HCV
RNA positive samples was determined. The prevalence of
HCV positive samples was 80%, 75%, 80%, 87% and 95%
for age groups 10–20 years, 21–30 years, 31–40 years,
41–50 years, and above 50 years, respectively. There
was no statistically significant difference in number of
HCV RNA positive samples between different age groups
(P > 0.05). The percentage of male HCV RNA positive
samples was higher in age group 31–40 years while most of
HCV RNA positive samples in age group 41–50 years were
from females (P < 0.05) (Figure 2).
Genotype 3a was found to be the most prevalent
genotype (160/177 = 90.3%), followed by genotypes 1a
(10/177 = 5.6%), 3b (1/177 = 0.6%), 4 (1/177 = 0.6%) and
mixed genotype (5/177 = 2.8%). Thus, genotype 3a was
significantly more abundant than 1a, 3b, type 4, and
mixed genotypes (P < 0.05) (Figure 3).
The prevalence of different HCV genotypes was also
stratified according to age groups 10–20 years, 21–30 years,
31–40 years, 41–50 years, and above 50 years and is
provided in Table 1. While genotype 3a was predominant
in all age groups, a high prevalence of genotype 1a and
mixed genotypes was observed in age group 41–50 years.
Mardan is located in the southwest of province Khyber
Pakhtunkhwa (KPK). Urban proportion of the district is
20.2% whereas 79.8% is the rural proportion. A report
conducted by Tehsils & Unions in the district Mardan,
Government of Pakistan has mentioned that compared
to urban areas HCV prevalence is more in rural areas.
Therefore, out of 215 sera, 50 were taken from urban
areas whereas 165 sera were taken from rural areas.
Prevalence of HCV genotypes has been reported from
different areas of Pakistan. Inamullah et al. [13] reported
genotype 3a (34.1%) as the most prevalent genotype in
district Swat followed by genotypes 2a (8.1%), 3b (7%),
1a (5.4%) and mixed genotype (7.6%). Ahmad et al. [14]
also found 49.5% prevalence of genotype 3a in district
Swat. Ali et al. [15] processed 415 HCV RNA positive
patients for genotyping from Khyber Pakhtunkhwa prov-
ince and found 57.83% prevalence of genotype 3a,
followed by 6.2% of genotype 3b. In a study conducted
in Lahore, Ahmad et al. [16] found 55.9% prevalence of
genotype 3a and 3.2% of genotype 3b. Overall, it has
been shown that genotype 3a is 62% prevalent among
HCV positive samples in Pakistan while prevalence of
3b, 1a, 2a and mixed genotypes is 9%, 3%, 2.144% and
4.718%, respectively [17]. In our study, we have alsoobserved that in 41–50 years age group, females have
high prevalence of HCV than males while this is reverse
in 31–40 years age group where males are more affected
than females. A total of 40 HCV seropositive samples
belonging to seven different locations of Baluchistan
were studied by Afridi et al. [18] and genotype 3a was
the most prevalent genotype among all samples.
When a comparative study was made among different
cities and districts of Pakistan including district Mardan,
genotype 3a was found to be the most common genotype
[17]. In this study, we have also compared the prevalence
of HCV among different age groups. We found that there
was no specificity of HCV dissemination among different
age groups and all groups showed closely related preva-
lence of HCV. Moreover, we observed difference of HCV
prevalence in males and females among different age
groups. The age group between 31–40 years showed that
males of this group are at high risk of having HCV infec-
tion while females of age group between 41–50 years
displayed high HCV infection rate than males. It will be
interesting to find out the factors involved in this gender
specification.
It is concluded that genotype 3a is the most prevalent
HCV genotype in Mardan. The higher prevalence of
HCV genotype 3a all around the Pakistan suggests that
Pakistani population is more susceptible to genotype 3a
as compared to other genotypes. Further studies on the
prevalence of HCV genotypes in different areas of
Pakistan involving large geography and population are
needed which will further help to strengthen and revise
preventive as well as therapeutic strategies throughout
the country.
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